Demographic and clinical characteristics of patients with NPSLE
| Female | 31 (96.9%) |
| Age, mean (SD in years) | 47.8 (12.5) |
| Education, mean (SD in years) | 11.9 (3.7) |
| Disease duration, mean (SD in years) | 5.3 (5.2) |
| SLEDAI-2K, mean (SD) | 5.3 (4.4) |
| SLICC/ACR Damage Index (SDI), mean (SD) | 0.29 (0.5) |
| aPL (+)ve | 3 (9.4%) |
| Smoking | 13 (41.9%) |
| NPSLE syndrome | |
| Mood disorder | 9 (27.3%) |
| Cognitive dysfunction | 6 (18.2%) |
| Anxiety disorder | 5 (15.2%) |
| Cerebrovascular disease | 4 (12.1%) |
| Psychosis | 3 (9.1%) |
| Cranial neuropathy | 2 (6.1%) |
| Acute confusional state | 1 (3.0%) |
| Seizures | 1 (3.0%) |
| Myelopathy | 1 (3.0%) |
| Polyneuropathy | 1 (3.0%) |
| HADS Anxiety, mean (SD) | 12.9 (4.6) |
| HADS Depression, mean (SD) | 10.3 (5.6) |
| HADS Anxiety ≥8 points | 21 (65.6%) |
| HADS Depression ≥8 points | 17 (53.1%) |
ACR, American College of Rheumatology; HADS, Hospital Anxiety and Depression Scale; NPSLE, neuropsychiatric SLE; SLEDAI-2K, Systemic Lupus Erythematosus Disease Activity Index; SLICC, Systemic Lupus International Collaborating Clinics.